Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Somnomed Limited ( (AU:SOM) ) has issued an update.
SomnoMed Limited has released its Corporate Governance Statement in line with the 4th Edition of the ASX Corporate Governance Principles and Recommendations. The statement outlines the company’s adherence to these principles, emphasizing the role of its Board in ensuring effective governance, strategic direction, and accountability. The Board’s responsibilities include overseeing management, approving strategic plans, and ensuring risk management frameworks are in place. The statement also details the procedures for appointing directors and senior executives, highlighting the importance of transparency and informed decision-making for shareholders.
The most recent analyst rating on (AU:SOM) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Somnomed Limited stock, see the AU:SOM Stock Forecast page.
More about Somnomed Limited
SomnoMed Limited operates within the healthcare industry, focusing on providing medical solutions for sleep-related disorders. The company is known for its oral appliance therapy products, which are designed to treat obstructive sleep apnea and snoring, targeting a global market of patients seeking non-invasive treatment options.
Average Trading Volume: 65,479
Technical Sentiment Signal: Hold
Current Market Cap: A$159.3M
For a thorough assessment of SOM stock, go to TipRanks’ Stock Analysis page.